EHA 2016 | EURO-SKI trial: stopping tyrosine kinase inhibitors in a very large cohort of European CML patients

Johan Richter

Press brief by Johan Richter, MD, PhD of the Skåne University Hospital Lund, Lund, Sweden, at the 2016 Annual Meeting of the European Association of Hematology (EHA), held in Copenhagen, Denmark.

Share this video